Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer

NCT01235052 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Bordeaux